Person: Feng Zhang

Feng Zhang, Core Institute Member at the Broad Institute and Professor at MIT

Feng Zhang Won $34.5 Million for Paediatric Epilepsy Editing. A Shared Platform Must Defeat Rare-Disease Economics

Feng Zhang’s ARPA-H-backed PERC consortium targets two severe childhood epilepsies first. Its real value will be whether one platform can lower the cost of treating many ultra-rare diseases.

Feng Zhang, Professor of Neuroscience at MIT and Core Institute Member at the Broad Institute

Asia Leaders

Feng Zhang Made Genome Editing Programmable. His New Tools Must Make It Deliverable

Feng Zhang’s laboratory has expanded the genome-editing toolbox again. The commercial test is whether smaller, safer systems can escape specialist centres and reach patients across Asia at viable cost.

Asia Leaders

Feng Zhang Found Smaller Gene-Editing Machinery. Delivery Will Decide Whether It Becomes a Therapeutic Platform

Feng Zhang’s laboratory continues to mine natural biology for programmable systems. Compact editors can fit into delivery vehicles that larger tools cannot, but therapeutic value will require precision, manufacturing and evidence beyond the discovery paper.

Person: Feng Zhang

Feng Zhang Won $34.5 Million for Paediatric Epilepsy Editing. A Shared Platform Must Defeat Rare-Disease Economics

Feng Zhang Made Genome Editing Programmable. His New Tools Must Make It Deliverable

Feng Zhang Found Smaller Gene-Editing Machinery. Delivery Will Decide Whether It Becomes a Therapeutic Platform

FigureAsia Magazine

Featured Lists